Skip to main content
Signal8

Newcomb Jessica

SEC insider (Form 3/4/5 filer). CIK 0002130408. Principal Accounting Officer at Tango Therapeutics, Inc. (TNGX). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 22, 2026. Located in BOSTON, MA.

Companies Newcomb Jessica has filed insider reports for

  • Tango Therapeutics, Inc. (TNGX): Officer, Principal Accounting Officer
Newcomb Jessica profile photo

Newcomb Jessica

CIK: 0002130408

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Tango Therapeutics, Inc. logo
TNGX

Tango Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Tango Therapeutics, Inc. logo
    TNGX

    Tango Therapeutics, Inc.

    Sep 22, 2026
    Sale
    Direct
    700 shares at avg. $22.80$16K
  • Tango Therapeutics, Inc. logo
    TNGX

    Tango Therapeutics, Inc.

    Sep 22, 2026
    Sale
    Direct
    5.1K shares at avg. $23.97$122K
  • Tango Therapeutics, Inc. logo
    TNGX

    Tango Therapeutics, Inc.

    Sep 22, 2026
    Sale
    Direct
    2.4K shares at avg. $25.17$60K

1-3 of 3